Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 29/11/2020
SIETES contiene 93170 citas

 1 a 20 de 215 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Geldhof A, Slater J, Clark M, Chandran U, Coppola D. Exposure to infliximab during pregnancy: post-marketing experience. Drug Saf 2020;43:febrero. [Ref.ID 103539]
2. Cita con resumen
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 2017;359:j5024. [Ref.ID 102147]
3. Cita con resumen
Shlomo M, Gorodischer R, Daniel S, Wiznitzer A, Matok I, Fishman B, Koren G, Levy A. The fetal safety of enoxaparin use during pregnancy: a population-based retrospective cohort study. Drug Saf 2017;40:1147-55. [Ref.ID 102105]
4. Cita con resumen
Sujan AC, Rickert ME, Öberg AS, Quinn PD, Hernández-Díaz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM. Association of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA 2017;317:1553-62. [Ref.ID 101557]
6. Cita con resumen
Gunn JKL, Rosales CB, Nuñez A, Gibson SJ, Christ C, Ehri JE. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:. [Ref.ID 100112]
7.Enlace a cita original Cita con resumen
Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N, on behalf of the network of French pharmacovigilance centres, Beghin D, Cuppers-Maarschalkerweerd B, Richardson JL, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Duman MK, Meister R, Schaefer C. Pregnancy outcome after TNF-a inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol 2015;80:727-39. [Ref.ID 99609]
8.Tiene citas relacionadas Cita con resumen
Trotta F, Da Cas R, Alegiani SS, Gramegna M, Venegoni M, Zocchetti C, Traversa G. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ 2014;348:g3361. [Ref.ID 98028]
9.Tiene citas relacionadas
Fell DB, Dodds L, McNeil S, MacDonald NE. H1N1 influenza vaccination during pregnancy. BMJ 2014;348:g3500. [Ref.ID 98025]
Artama M, Gissler M, Malm H, Ritvanen A, The Drug and Pregnancy Group. Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69. [Ref.ID 95519]
11.Tiene citas relacionadas Cita con resumen
Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013;346:10. [Ref.ID 95433]
12.Tiene citas relacionadas
Lucas R, Xiang F, Ponsonby A-L. Vitamin D sufficiency in pregnancy. BMJ 2013;346:7. [Ref.ID 95432]
13. Cita con resumen
Pasternak B, Svanström H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med 2013;368:814-23. [Ref.ID 94997]
14. Cita con resumen
Rubinstein F, Micone P, Bonotti A, Wainer V, Schwarcz A, Augustovski F, Riviere AP, Karolinski A, on behalf of "EVA" Study Research Group (Estsudio "Embarazo y Vacuna Antigripal"). Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ 2013;346:14. [Ref.ID 94977]
16.Tiene citas relacionadas
Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990—2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223. [Ref.ID 94240]
17.Tiene citas relacionadas
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990—2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96. [Ref.ID 94239]
18.Tiene citas relacionadas
Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990—2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012;380:2144-62. [Ref.ID 94238]
19.Tiene citas relacionadas
Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012;380:2129-43. [Ref.ID 94237]
20.Tiene citas relacionadas
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-118. [Ref.ID 94236]
Seleccionar todas
 1 a 20 de 215 siguiente >>